Targeted NGS for Drug‑Resistant Tuberculosis Detection and Surveillance

This expert presentation explores how WHO‑recommended targeted next‑generation sequencing (NGS) is being used to enhance drug‑resistant tuberculosis (TB) detection and surveillance in a high‑TB burden country setting. Dr. Shaheed Vally Omar shares experience from implementing targeted sequencing approaches within a national reference laboratory framework.

The session focuses on how standardized and simplified NGS workflows can support surveillance programs, improve detection of resistance‑associated mutations, and strengthen public health responses to drug‑resistant TB. 

What you’ll learn:

• How targeted NGS supports drug‑resistant TB detection and surveillance 

• Practical considerations for implementing WHO‑recommended sequencing approaches

• The role of genomics in strengthening national TB surveillance programs

Presenter:
Shaheed Vally Omar, PhD
Scientific Lead, Centre for Tuberculosis
National Institute for Communicable Diseases (NICD/NHLS), South Africa